Quarterly Updates30 May 2026, 09:21 pm
Astal Labs FY26: Revenue at ₹155.19 Mn, Net Profit ₹108.66 Mn
AI Summary
Astal Laboratories Ltd announced audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board of Directors approved these results on May 30, 2026. Revenue from operations for FY26 stood at ₹155.19 million, with a net profit of ₹108.66 million. The auditor's report has an unmodified opinion. The company focuses on manufacturing Pharmaceutical Ingredients (Bulk Drugs).
Key Highlights
- Astal Labs' FY26 revenue from operations reached ₹155.19 million.
- The company reported a net profit of ₹108.66 million for FY26.
- Auditors issued an unmodified opinion on the financial results.
- Board approved results on May 30, 2026, following audit committee review.
- Basic earning per share (EPS) stood at 2.189.
Price Impact
More from MACINTR